echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Cinda PD-1 sales of 500 million in the second quarter.

    Cinda PD-1 sales of 500 million in the second quarter.

    • Last Update: 2020-08-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Sales in the first half of the year alone are close to full-year sales.
    , Cinda Bio announced the latest sales of its PD-1 second company, announcing that its Cindy Singli Singanti selling revenue in the second quarter of 2020 was about 500 million yuan.
    according to the previous relevant announcement can be seen, Cindy Singli sing-at-com sales in the first section of 2020 400 million yuan, that is, Cinda PD-1 Cindili sales in the first half of this year has been close to last year's full year's 1 billion yuan, but also close to the 100-time Meigui "O drug" 2019 sales in China, the current domestic PD-1 drug companies, only Cinda Bio Cindili single resistance into the health care catalog.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.